Frontlight ResearchEarly access
CompletedNo phase
A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis
Key facts
- Who runs it
- Nemours Children's Clinic
- Where
- Orlando, Seattle, and Wilmington, United StatesSee the 3 sites
- Trial code
- Status
- Completed
- People taking part
- 22 people enrolled
- Started
- 12 Nov 2018
- Ended
- 31 Dec 2023
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- DED
- FREE
- Record updated
- 10 February 2025
Who can take part
- Age
- 2 years to 18 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- An Institutional Review Board (IRB) approved written Parental Permission form is signed and dated by the parent or legal representative/caregiver
- If applicable, an Institutional Review Board (IRB) approved written Assent form is signed and dated by the participant
- The participant/parent(s) or legal representative(s)/caregiver(s) are considered reliable and capable of adhering to the protocol call schedule and dietary requirements
- The participant is >2 years to <18 years of age
- The participant has isolated esophageal eosinophilia (>15 eos/hpf)
- The family has access to the internet to complete weekly surveys and to a telephone to complete weekly follow up calls
- The biopsy used to diagnose eosinophilic esophagitis was taken no more than 12 weeks prior to the date of enrollment
Who cannot take part
- The participant has concomitant GI inflammatory conditions (e.g. celiac disease, inflammatory bowel disease)
- The participant is currently taking a PPI (If discontinued, no washout required.)
- The participant is currently on or previously failed a dairy free diet for EoE
- The participant has a history of upper GI tract surgery (e.g. fundoplication)
- The participant has other significant medical conditions that, in the opinion of the provider, would impact the participant's ability to participate in the study
- The participant has a psychiatric condition that, in the opinion of the investigator, could jeopardize the participant's ability to participate in the study
- The participant has peripheral eosinophilia > 1,500 µL
- Acid reflux by pH probe is suggested (*A pH probe is not required, but may be done as standard of care)
- The participant has severe developmental delay that, in the opinion of the investigator, could jeopardize the participant's ability to participate in the study
- The participant has taken prednisone in the last 12 weeks, or has taken fluticasone or budesonide in the last 8 weeks
- The participant does not speak or read English fluently
Where in United States
- Nemours Children's HospitalOrlando, United States
- Seattle Children's HospitalSeattle, United States
- Nemours/Alfred I. duPont Hospital for ChildrenWilmington, United States
About the trial
What the trial wants to find out
Prospective, pragmatic standard of care clinical trial comparing dietary therapies of standard dairy elimination diet alone (DED) to dairy elimination plus food additive elimination (FREE)
The 2 groups in the trial
- DEDExisting treatment, for comparison
Diet eliminating dairy
- FREEExisting treatment, for comparison
Diet eliminating dairy and food additives
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 10 February 2025